Moderate dose radiotherapy effective in EORTC trial for patients with desmoid-type fibromatosis
A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in ...
Jul 18, 2013
0
0